Investment Underground
Investment Underground
Stop FollowingInvestment Underground
View as an RSS Feed
View Investment Underground's Articles BY TICKER:
AA,
AAPL,
ABT,
ABX,
ACN,
AES,
AMGN,
AMZN,
APA,
APC,
APOL,
ARNA,
ARR,
ATPG,
ATVI,
AU,
AXP,
BA,
BAC,
BBRY,
BBT,
BHP,
BIDU,
BMY,
BP,
BRK.A,
BRK.B,
C,
CHK,
CIM,
CLD,
COG,
COP,
CRUS,
CSCO,
CTL,
CTRP,
CVX,
DAL,
DD,
DNDN,
EBAY,
EKDKQ.PK,
EOG,
ETE,
EXC,
F,
FCX,
FSLR,
FST,
FTR,
GE,
GG,
GM,
GMCR,
GOOG,
GS,
GSK,
HD,
HES,
HPQ,
IBM,
INTC,
JNJ,
JPM,
KERX,
KMI,
KMX,
KO,
KOG,
LCC,
LLY,
LMT,
LNKD,
LULU,
MCD,
MCP,
MDT,
MNKD,
MO,
MRK,
MRO,
MSFT,
MSG,
MU,
NBL,
NFLX,
NFX,
NLY,
NOK,
NVS,
ORCL,
P,
PEP,
PFE,
PG,
QCOR,
RF,
RIO,
S,
SD,
SIRI,
SJI,
SLW,
SNY,
SPPI,
T,
VALE,
VLO,
VMC,
VRX,
VVUS,
VXX,
VZ,
WEN,
WFC,
WFM,
WIN,
WMT,
WYNN,
XOM,
YHOO,
Z,
ZNGA
- 3 'Made In America' Stocks To Buy Now For Gains In 2013
- 3 Oil And Gas Stocks To Buy Now Instead Of Chesapeake
- Exxon: Now A High Growth Stock On New Rosneft Deal
- 4 New Problems That Could Hurt Amazon's Stock Today
- Johnson & Johnson's 7% Dividend Hike Backed By New Acquisition, High Cash Flow
- 2 Financial Preferreds For 8% Gains
- AT&T: Why You Should Be Bullish On This Telecom Titan
- 3 Trust Preferreds For High Yields Now
- Exxon Mobil's 29.5 Billion Barrel Reserves Will Reward Investors Now
- Apache's 54% Production Increase Means Massive Gains For Investors
- 3 Oil And Gas Stocks For Income Now
- 3 Big Reasons To Be Bullish On Apache Now
- Netflix Ready To Tank On Lower Subscriber Growth
- 3 High-Yield Preferreds For Income Now
- Altria Ready To Climb Higher On New Blends, Snus Brands
- Pfizer Will Surge Above $22 High On Strong Drug Portfolio
- GE's New 'Reflective Memory' Will Make You Money
- Nokia Ready To Soar On Lumia 900 Success
- Goldcorp Ready To Skyrocket On New Projects In 2013
- 3 Trust Preferred Stocks To Consider Now
- Spectrum Could Sink In Wake Of Trial Failures
- Research In Motion: The Blackberry 10 Can't Save This Stock
- 3 Hot Financial Preferreds To Consider
- 2 Big Reasons To Be Bullish On Chesapeake Today
- 5 Biotech Stocks That Could Soar On New Hepatitis C Drugs
- Valeant Ready To Spring Higher On New Atlantis Pharma Deal
- IBM Will Break $210 High On Latest Acquisitons
- Arena Pharmaceuticals' Outlook Hinges On Success Of Lorcaserin
- Sprint Ready To Break $4 In 2013
- Human Genome Sciences: Benlysta's Slow Start Will Hold Stock Down
- Buy Low, Sell High: Netflix's New Features Will Shoot Stock Higher In 2013
- Kodiak Oil & Gas: Can This Speculative Stock Double By 2014?